Microbot Medical to open Endovascular Robotics session at SRS meeting MBOT
POAI Stock | USD 0.79 0.01 1.28% |
Under 51% of Predictive Oncology's investor base is interested to short. The analysis of overall sentiment of trading Predictive Oncology stock suggests that many investors are impartial at this time. Predictive Oncology's investing sentiment shows overall attitude of investors towards Predictive Oncology.
Predictive | Build AI portfolio with Predictive Stock |
Microbot Medical announce... MBOT
Read at thefly.com
![]() |
Predictive Oncology Fundamental Analysis
We analyze Predictive Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Predictive Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Predictive Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Predictive Oncology is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Predictive Oncology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Predictive Oncology stock to make a market-neutral strategy. Peer analysis of Predictive Oncology could also be used in its relative valuation, which is a method of valuing Predictive Oncology by comparing valuation metrics with similar companies.
Peers
Predictive Oncology Related Equities
MHUA | Meihua International | 4.65 | ||||
NAOV | NanoVibronix | 3.06 | ||||
PHIO | Phio Pharmaceuticals | 0.82 | ||||
STSS | Sharps Technology | 0.69 | ||||
LUCY | Innovative Eyewear | 1.41 | ||||
GCTK | GlucoTrack | 1.52 | ||||
MBOT | Microbot Medical | 1.98 | ||||
SLRX | Salarius Pharmaceuticals | 3.17 |
Complementary Tools for Predictive Stock analysis
When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |